‘Cura Zika’ to Accelerate International Research on Devastating Epidemic
• Celina Turchi Martelli, M.D., Ph.D., senior public health scientist, Brazilian Ministry of Health’s Fundação Oswaldo Cruz Foundation
• Yoel Sadovsky, M.D., Elsie Hilliard Hillman Professor of Women’s and Infants’ Health Research, Pitt School of Medicine; scientific director, Magee-Womens Research Institute
WHEN: Thursday, May 5
• 12:30 p.m., press availability
• 1 to 3 p.m., symposium
WHERE: Pitt Public Health Auditorium (G23), 130 DeSoto St., Pittsburgh, 15261
WHY: Zika is a mosquito-borne and sexually transmitted virus that causes microcephaly in infants born to mothers infected with it while pregnant. It also is associated with increased risk of Guillain-Barre syndrome and other neurological disorders in people who contract it. The virus is widespread in South and Central America and has a likelihood of gaining sustained transmission in the southern U.S. this summer.
Cura Zika builds on Pitt Public Health’s long-standing collaboration with FIOCRUZ, the most prominent science and technology health institution in Latin America.
Cura Zika—which means “Cure Zika” in both Portuguese and Spanish—will provide quick-access funding to scientists performing time-sensitive research on the virus. This support is designed to move early stage innovative research ideas into larger studies in an accelerated manner.
Note to Media:
To cover this event, prior arrangements must be made by contacting Allison Hydzik at 412-647-9975